Category News

DePuy Synthes Receives FDA Clearance for TriLEAP™ Lower Extremity Anatomic Plating System

DePuy Synthes Receives FDA Clearance for TriLEAP™ Lower Extremity Anatomic Plating System Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)…

Read MoreDePuy Synthes Receives FDA Clearance for TriLEAP™ Lower Extremity Anatomic Plating System

Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies

Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline long-term results from the global phase…

Read MoreRoche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies

RevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures

RevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures RevBio, Inc., announced that it has been awarded a grant from the National Institute on Aging (NIA), part of the National Institutes of…

Read MoreRevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures

AIS Healthcare’s Advanced Infusion Care Team Presents at Immunoglobulin National Society Conference

Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12th National Conference, which takes place on October 5th – 8th in Denver, Colorado. The annual conference provides a forum for industry leaders across…

Read MoreAIS Healthcare’s Advanced Infusion Care Team Presents at Immunoglobulin National Society Conference

Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases

Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2023 held in Boston…

Read MorePfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases

MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress

MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to…

Read MoreMindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress

Hey Jane Launches Comprehensive Reproductive and Sexual Health Services in the District of Columbia

Hey Jane Launches Comprehensive Reproductive and Sexual Health Services in the District of Columbia Hey Jane, the patient-centered, virtual reproductive and sexual health care clinic, announced the expansion of its services to the District of Columbia. This launch not only…

Read MoreHey Jane Launches Comprehensive Reproductive and Sexual Health Services in the District of Columbia

Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the Cyto-Mine® platform has been selected by FairJourney Biologics, a world…

Read MoreSphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

ew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZAto Support Thyroid Eye Disease Patient Outcomes

ew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data showing that disrupting the recommended TEPEZZA treatment regimen by…

Read Moreew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZAto Support Thyroid Eye Disease Patient Outcomes